Episodic vs. Chronic Migraine
For the purposes of this study, episodic and chronic migraine are defined as follows:
Episodic
• Participants must experience between two and 14 migraine days per month for three months prior to enrollment.
• Participants must have a diagnosis of episodic migraine for at least two years.
Chronic
• Participants must experience at least 15 or more headache days per month for three months prior to enrollment, and eight or more of those headaches must be migraine.
• Participants must have a diagnosis of chronic migraine for at least two years.
tance in the RAM study were women. To further refine their results, the researchers are enrolling for a new study, Aspirin Resistance in Women with Migraine( ARWM), at the University of Washington in Seattle. This study extends the initial research by using a larger sample size and administering only 81 mg of aspirin, which is the recommended dose for primary and secondary prevention of heart attack and stroke. The study is designed to compare the prevalence of aspirin resistance in women with episodic and chronic migraine to that of women without migraine. Secondary aims will include comparisons of aspirin resistance between episodic and chronic migraineurs and between migraineurs with and without aura.
Jesurum is seeking premenopausal women between the ages of 18 and 55 who have been diagnosed with episodic or chronic migraine to enroll in the study. Participants will be required to make three one-hour visits to the Seattle area within a one-month period and provide a blood sample( 15 cc) at each of the visits. HW
If you are a migraineur who is interested in participating in this study, please contact research coordinator Elisa McGee at 206-598-9260 or emcgee @ uw. edu. If you are a medical provider or researcher and would like to know more about the study, contact Jill Jesurum, PhD, at jill. jesurum @ swedish. org.
www. headwisemag. org | National Headache Foundation 17